ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 177 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q4 2016. The put-call ratio across all filers is 0.97 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $11,876,000 | -27.4% | 168,915 | -26.8% | 1.49% | -27.5% |
| Q3 2016 | $16,361,000 | -1.0% | 230,628 | -31.7% | 2.06% | -12.3% |
| Q2 2016 | $16,521,000 | -13.3% | 337,788 | +12.2% | 2.34% | -6.8% |
| Q1 2016 | $19,062,000 | -17.7% | 301,091 | +45.8% | 2.52% | -7.6% |
| Q4 2015 | $23,172,000 | +16.3% | 206,559 | -0.2% | 2.72% | +17.9% |
| Q3 2015 | $19,925,000 | -25.0% | 206,880 | -20.3% | 2.31% | -14.4% |
| Q2 2015 | $26,584,000 | – | 259,633 | – | 2.70% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| First Light Asset Management, LLC | 213,887 | $29,608,000 | 2.19% |
| Rock Springs Capital Management LP | 566,500 | $78,421,000 | 1.66% |
| FEDERATED HERMES, INC. | 4,280,528 | $592,554,000 | 1.21% |
| AtonRa Partners | 17,646 | $2,443,000 | 1.20% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 218,390 | $30,232,000 | 1.05% |
| EMERALD ADVISERS, LLC | 226,875 | $31,406,000 | 1.04% |
| Atika Capital Management LLC | 89,000 | $12,319,000 | 0.96% |
| Capital Impact Advisors, LLC | 25,582 | $3,541,000 | 0.87% |
| JGP Global Gestao de Recursos Ltda. | 1,586 | $220,000 | 0.83% |
| CAPITAL INTERNATIONAL LTD /CA/ | 79,742 | $11,039,000 | 0.64% |